Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


16.08.2021

1 Alzheimers Dement
1 Am J Geriatr Psychiatry
2 BMC Geriatr
1 BMC Neurosci
1 Brain
15 J Alzheimers Dis
1 J Biol Chem
2 N Engl J Med
1 Nat Rev Neurol
2 Neurobiol Aging
1 Neurobiol Dis
5 Neurochem Res
2 Neurology
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Alzheimers Dement

  1. GHAZARIAN AL, Haim T, Sauma S, Katiyar P, et al
    National Institute on Aging seed funding enables Alzheimer's disease startups to reach key value inflection points.
    Alzheimers Dement. 2021 Aug 10. doi: 10.1002/alz.12392.
    PubMed         Abstract available


    Am J Geriatr Psychiatry

  2. CHAN NK, Gerretsen P, Chakravarty MM, Blumberger DM, et al
    Structural Brain Differences Between Cognitively Impaired Patients With and Without Apathy.
    Am J Geriatr Psychiatry. 2021;29:319-332.
    PubMed         Abstract available


    BMC Geriatr

  3. SU H, Sun X, Li F, Guo Q, et al
    Association between handgrip strength and cognition in a Chinese population with Alzheimer's disease and mild cognitive impairment.
    BMC Geriatr. 2021;21:459.
    PubMed         Abstract available

  4. KOBAYASHI M, Honda M
    The effect of a multimodal comprehensive care methodology for family caregivers of people with dementia.
    BMC Geriatr. 2021;21:434.
    PubMed         Abstract available


    BMC Neurosci

  5. KILE S, Au W, Parise C, Rose K, et al
    Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease.
    BMC Neurosci. 2021;22:49.
    PubMed         Abstract available


    Brain

  6. STROM A, Iaccarino L, Edwards L, Lesman-Segev OH, et al
    Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Brain. 2021 Aug 9. pii: 6346980. doi: 10.1093.
    PubMed         Abstract available


    J Alzheimers Dis

  7. KIM HR, Jang JH, Ham H, Choo SH, et al
    A Case of Early-Onset Alzheimer's Disease Mimicking Schizophrenia in a Patient with Presenilin 1 Mutation (S170P).
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210650. doi: 10.3233/JAD-210650.
    PubMed         Abstract available

  8. NOUS A, Wittens MMJ, Vermeiren Y, De Deyn PP, et al
    Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer's Disease but Are Not Correlated with Cognitive Decline.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210562. doi: 10.3233/JAD-210562.
    PubMed         Abstract available

  9. AGUERO P, Sainz MJ, Tellez R, Lorda I, et al
    De Novo PS1 Mutation (Pro436Gln) in a Very Early-Onset Posterior Variant of Alzheimer's Disease Associated with Spasticity: A Case Report.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210420. doi: 10.3233/JAD-210420.
    PubMed         Abstract available

  10. LI Y, Wang R, Li Q, Wang YJ, et al
    Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210381. doi: 10.3233/JAD-210381.
    PubMed         Abstract available

  11. RASMUSSEN ID, Boayue NM, Mittner M, Bystad M, et al
    High-Definition Transcranial Direct Current Stimulation Improves Delayed Memory in Alzheimer's Disease Patients: A Pilot Study Using Computational Modeling to Optimize Electrode Position.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210378. doi: 10.3233/JAD-210378.
    PubMed         Abstract available

  12. TADOKORO K, Yamashita T, Kimura S, Nomura E, et al
    Retinal Amyloid Imaging for Screening Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210327. doi: 10.3233/JAD-210327.
    PubMed         Abstract available

  13. HE H, Liu A, Zhang W, Yang H, et al
    Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210307. doi: 10.3233/JAD-210307.
    PubMed         Abstract available

  14. VAN ZELLER M, Dias DM, Sebastiao AM, Valente CA, et al
    NLRP3 Inflammasome: A Starring Role in Amyloid-beta- and Tau-Driven Pathological Events in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 4. pii: JAD210268. doi: 10.3233/JAD-210268.
    PubMed         Abstract available

  15. CAI HY, Yang D, Qiao J, Yang JT, et al
    A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 4. pii: JAD210256. doi: 10.3233/JAD-210256.
    PubMed         Abstract available

  16. PUDUMJEE SB, Lundt ES, Albertson SM, Machulda MM, et al
    A Comparison of Cross-Sectional and Longitudinal Methods of Defining Objective Subtle Cognitive Decline in Preclinical Alzheimer's Disease Based on Cogstate One Card Learning Accuracy Performance.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD210251. doi: 10.3233/JAD-210251.
    PubMed         Abstract available

  17. VAN DE MORTEL LA, Thomas RM, van Wingen GA
    Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210173. doi: 10.3233/JAD-210173.
    PubMed         Abstract available

  18. CARCAMO J, Kociolek AJ, Fernandez KK, Gu Y, et al
    Neuropsychological Predictors of Severe Functional Dependency in a Multiethnic Community Cohort of Individuals with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210019. doi: 10.3233/JAD-210019.
    PubMed         Abstract available

  19. PARK M, Baik K, Lee YG, Kang SW, et al
    Implication of Small Vessel Disease MRI Markers in Alzheimer's Disease and Lewy Body Disease.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD210669. doi: 10.3233/JAD-210669.
    PubMed         Abstract available

  20. YU Y, Gao Y, Winblad B, Tjernberg L, et al
    A Super-Resolved View of the Alzheimer's Disease-Related Amyloidogenic Pathway in Hippocampal Neurons.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD215008. doi: 10.3233/JAD-215008.
    PubMed         Abstract available

  21. MUKHOPADHYAY S, Banerjee D
    A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD215065. doi: 10.3233/JAD-215065.
    PubMed         Abstract available


    J Biol Chem

  22. PERDIGAO C, Barata MA, Burrinha T, Almeida CG, et al
    Alzheimer's disease BIN1 coding variants increase intracellular Abeta levels by interfering with BACE1 recycling.
    J Biol Chem. 2021 Aug 7:101056. doi: 10.1016/j.jbc.2021.101056.
    PubMed         Abstract available


    N Engl J Med

  23. ESPAY AJ
    Donanemab in Early Alzheimer's Disease.
    N Engl J Med. 2021;385:666-667.
    PubMed        

  24. MINTUN MA, Wessels AM, Sims JR
    Donanemab in Early Alzheimer's Disease. Reply.
    N Engl J Med. 2021;385:667.
    PubMed        


    Nat Rev Neurol

  25. YU M, Sporns O, Saykin AJ
    Author Correction: The human connectome in Alzheimer disease - relationship to biomarkers and genetics.
    Nat Rev Neurol. 2021 Aug 11. pii: 10.1038/s41582-021-00554.
    PubMed        


    Neurobiol Aging

  26. NAUDE PJW, Ramakers IHGB, van der Flier WM, Jiskoot LC, et al
    Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer's disease dementia.
    Neurobiol Aging. 2021;107:1-10.
    PubMed         Abstract available

  27. LEMERCIER P, Vergallo A, Lista S, Zetterberg H, et al
    Association of plasma Abeta40/Abeta42 ratio and brain Abeta accumulation: testing a whole-brain PLS-VIP approach in individuals at risk of Alzheimer's disease.
    Neurobiol Aging. 2021;107:57-69.
    PubMed         Abstract available


    Neurobiol Dis

  28. WANG X, Zhou X, Uberseder B, Lee J, et al
    Isoform-specific dysregulation of AMP-activated protein kinase signaling in a non-human primate model of Alzheimer's disease.
    Neurobiol Dis. 2021;158:105463.
    PubMed         Abstract available


    Neurochem Res

  29. GONZALEZ A
    Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.
    Neurochem Res. 2021;46:34-50.
    PubMed         Abstract available

  30. SHARMA VK, Singh TG, Singh S, Garg N, et al
    Apoptotic Pathways and Alzheimer's Disease: Probing Therapeutic Potential.
    Neurochem Res. 2021 Aug 12. pii: 10.1007/s11064-021-03418.
    PubMed         Abstract available

  31. GAO Y, Zhang J, Li S, Zhang Y, et al
    Cattle Encephalon Glycoside and Ignotin Protects Neurons Against Microglia-Induced Neuroinflammation via Elevating BDNF Expression and Inhibiting TLR4/NF-kappaB Pathway.
    Neurochem Res. 2021;46:326-336.
    PubMed         Abstract available

  32. LARANJINHA J, Nunes C, Ledo A, Lourenco C, et al
    The Peculiar Facets of Nitric Oxide as a Cellular Messenger: From Disease-Associated Signaling to the Regulation of Brain Bioenergetics and Neurovascular Coupling.
    Neurochem Res. 2021;46:64-76.
    PubMed         Abstract available

  33. CHU F, Li K, Li X, Xu L, et al
    Graphene Oxide Ameliorates the Cognitive Impairment Through Inhibiting PI3K/Akt/mTOR Pathway to Induce Autophagy in AD Mouse Model.
    Neurochem Res. 2021;46:309-325.
    PubMed         Abstract available


    Neurology

  34. BUCIUC M, Duffy JR, Machulda MM, Graff-Radford J, et al
    Clinical, Imaging, and Pathologic Characteristics of Patients With Right Versus Left Hemisphere-Predominant Logopenic Progressive Aphasia.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012322.
    PubMed         Abstract available

  35. LI J
    Alzheimer's Villanelle.
    Neurology. 2021 Aug 10. pii: WNL.0000000000012612.
    PubMed        


    PLoS One

  36. HUI J, Zhao Y, Yu S, Liu J, et al
    Detection of retinal changes with optical coherence tomography angiography in mild cognitive impairment and Alzheimer's disease patients: A meta-analysis.
    PLoS One. 2021;16:e0255362.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: